Kanis, J. A.
,
Cooper, C.
Rizzoli, R.
Reginster, J.-Y.
Article History
Received: 25 October 2018
Accepted: 26 October 2018
First Online: 5 January 2019
Compliance with ethical standards
:
: JAK reports grants from Amgen, Eli Lilly and Radius Health; non-financial support from Medimaps, and Asahi; and other support from AgNovos. JAK is the architect of FRAX<sup>®</sup> but has no financial interest. CC reports personal fees from Alliance for Better Bone Health, Amgen, Eli Lilly, GSK, Medtronic, Merck, Novartis, Pfizer, Roche, Servier, Takeda and UCB. RR has received consulting fees or advisory board fees from Radius Health, Labatec, Danone, Nestlé, CNIEL and Sandoz. J-YR has received advisory board or consulting fees from IBSA-Genévrier, Pierre Fabre, Radius Health, TEVA and Mylan; and lecture fees from Anovos, IBSA-Genévrier, Mylan, CNIEL, Dairy Research Council (DRC) and Theramex; and institutional grant support from IBSA-Genévrier, Mylan, CNIEL and Radius Health.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: For this type of study, formal consent is not required.